TRIO conducts novel clinical trials with designs scientifically based on the preclinical findings from the Translational Oncology Research Laboratory (TORL) at UCLA.Īdditional information on TRIO is available at Our mission is to further cancer research through our translational research model led by Dr. We are dedicated to advancing translational cancer research by bringing innovative and targeted therapeutics to clinical practice.
#DMG ONCOLOGY FULL#
TRIO together with its global network of dedicated investigators is a notforprofit academic oncology research organization offering full CRO services to conduct its clinical trials. “We look forward to enlightening our audience on clinical health and the treatment options available.”
#DMG ONCOLOGY TRIAL#
“While many remain unaware, it is so important for patients to become knowledgeable and understand that a clinical trial is a very good treatment option for their disease,” said Michele Nehls, Producer for the Innovations series. In addition, the show will address many of the common concerns associated with clinical trials, and will explain how clinical trials are rigorously reviewed by the FDA and hospital Ethics Committees so that patients are ensured to get nothing less than the best available standard of care. Dennis Slamon TRIO Director and Chief of the Hematology/Oncology division at the University of California, Los Angeles. This in turn will render a cancer a chronic “living” disease as opposed to a fatal one,” said Dr.
“A patient’s contribution to clinical trials is essential in furthering cancer research and makes them true colleagues in finding new treatments that lead to cures and/or more effective treatments. Viewers will learn how important their involvement in the testing of new anticancer drugs and combinations through a clinical trial is for the continued advancement of improving cancer treatments. This segment of Innovations will focus on clinical trials and what it means to participate in a clinical trial as a cancer patient. Check your local listing for airings outside of the United States. DecemClinical Trials Studies Explored in Upcoming Episode of Innovations Featuring Translational Research in Oncology (TRIO) DMG Productions explores the latest scientific breakthroughs in clinical healthĮDMONTON, Canada(BUSINESS WIRE)Translational Research in Oncology (TRIO) announced today that they will be featured in an upcoming episode of Innovations with Ed Begley Jr., airing via the Discovery Channel on Monday, Decemat 7:30aET and 7:30aPT.
0 kommentar(er)
